BofAS: KINGDEE INT'L Projected to Maintain Steady Revenue Growth in 2025, Adjusted Net Profit Aligned with Expectations
Positive Profit Alert: KINGDEE INT'L issued a positive profit alert, projecting FY25 operating revenue to grow by 12% YoY to RMB7 billion and adjusted net profit to reach RMB215 million, aligning with market expectations.
Revenue Growth Drivers: BofA Securities attributed the revenue growth to strong expansion in the large enterprise business and an increase in new orders from SMEs, indicating improved downstream demand in 2H25.
Stock Rating and Target Price: BofA Securities maintained a "Buy" rating for KINGDEE INT'L, setting a target price of HKD20.2.
Short Selling Activity: The company experienced short selling of $86.83 million, with a short selling ratio of 22.947%.
Trade with 70% Backtested Accuracy
Analyst Views on 00268
About the author
HSI Rises 435 Points as JD-SW Jumps 10% and JD LOGISTICS Soars 23%
Hong Kong Stock Market Performance: Hong Kong stocks saw significant gains, with the HSI rising 1.7% to 25,757, the HSCEI up 2.1% to 8,628, and the HSTECH increasing 3.2% to 4,947, alongside a total market turnover of $292.766 billion.
JD Series Surge: JD-SW shares surged nearly 10% to $106.6 following positive results, while JD LOGISTICS experienced a remarkable 23% increase, making it the largest gainer among blue chips.
Tech Stocks Rally: Major tech companies like TENCENT, BABA-W, and MEITUAN-W saw their stock prices rise between 3.1% and 5.2%, reflecting a broader positive trend in the tech sector.
BILIBILI-W Decline: Despite reporting a 94% increase in adjusted net profit, BILIBILI-W's stock price fell by 4.5%, contrasting with other companies that experienced gains.
HSI Rises 468 Points at Midday; JD Jumps Over 8% After Earnings; Tencent, Alibaba, and Meituan Gain 4%
Market Performance: The Hong Kong bourse experienced a strong morning session, with the Hang Seng Index (HSI) rising 468 points (1.85%) to close at 25,789, driven by gains in technology stocks.
JD Companies Surge: JD's various subsidiaries saw significant stock price increases following their earnings release, with JD Logistics soaring 21.3% and JD Health rising 3.5%.
Tech Stocks Gains: Major tech companies like Tencent, Alibaba, and Meituan also posted notable gains, with increases ranging from 3.9% to 4.3%, contributing to the overall market upswing.
AI and Cloud Stocks: AI-related stocks and cloud service providers experienced growth, with companies like Kingsoft Cloud and various AI firms seeing increases of 3.7% to 5.7%, while Bilibili's stock fell despite reporting a significant profit increase.
HSBC Research Lowers KINGDEE INT'L (00268.HK) Price Target to $17.7, Maintains Buy Rating
Share Price Movement: KINGDEE INT'L's share price has decreased by 3.027% recently, despite a 24% year-to-date increase, amid concerns about AI's impact on software.
HSBC Global Research Insights: HSBC believes that while AI can enhance ERP systems, it will not replace them due to the complexity and high expectations of corporate clients.
Revenue Model Differences: Unlike the US software sector, KINGDEE INT'L charges based on the number of modules used rather than a seat-based model, reflecting the competitive landscape in China.
Profit Forecast Adjustments: HSBC has lowered its net profit forecasts for KINGDEE INT'L by 14-25% for 2025-2027, while maintaining a Buy rating and adjusting the target price from $18.2 to $17.7.
HSI Closes Down 491 Points; Tech, Pharma, and Chinese Insurers Decline, While STANCHART Surges Over 3% After Earnings Report
Market Performance: The HSI fell by 491 points (1.8%) to 26,590, with the HSCEI and HSTECH also experiencing declines of 2.1%, closing at 9,007 and 5,270 respectively, amid a total market turnover of HKD250.992 billion.
Tech Stock Declines: Major tech stocks like TENCENT, BABA-W, and MEITUAN-W saw significant drops, with short selling ratios indicating high market activity, reflecting a broader downturn in the tech sector.
Pharmaceutical Sector Struggles: Pharmaceutical stocks continued to decline, with CSPC PHARMA and SINO BIOPHARM among the biggest losers, as short selling activity remained high in this sector.
Financial Sector Highlights: STANCHART reported a 3.1% increase in stock price after announcing a significant rise in dividend distribution, contrasting with the overall negative trend seen in Chinese insurers, which experienced declines.
HSI Declines 523 Points at Midday; KNOWLEDGE ATLAS Gains 20%; Tech, Pharma, and Chinese Insurers Underperform
Market Performance: The HSI fell 523 points (1.9%) to 26,558, with the HSCEI down 190 points (2.1%) and the HSTECH dropping 127 points (2.4%), amid a total turnover of HKD138.679 billion.
Tech Stocks Decline: Major tech stocks like TENCENT, BABA-W, and MEITUAN-W experienced significant declines, with short selling ratios indicating increased bearish sentiment.
AI and Robotics Sector Struggles: Stocks in the AI sector, including SENSETIME-W and PHANCY, saw substantial losses, while robotics stocks like DOBOT plunged over 10%.
Pharmaceutical and Insurance Stocks Down: Pharma stocks such as CSPC PHARMA and Chinese insurers like CHINA LIFE faced declines of 4-6%, reflecting a broader downturn in these sectors.
G Sachs: KINGDEE INT'L (00268.HK) Anticipated to Report Over RMB60M Profit Last Year, Falling Short of Projections; Target Price Reduced to $18.21
Goldman Sachs Outlook: Goldman Sachs maintains a positive outlook on KINGDEE INT'L (00268.HK), leveraging AI and corporate data to enhance productivity, despite a recent stock decline of 5.645%.
Profit Forecast: KINGDEE INT'L is expected to turn a profit in 2025, projecting a net profit of RMB60-100 million, although this is lower than previous estimates of RMB178 million.
Revised Profit Estimates: Goldman Sachs has reduced its profit forecasts for KINGDEE INT'L for 2025-2027 by 47%, 8%, and 6% respectively, citing higher-than-expected operating expenses.
Target Price Adjustment: The broker has lowered its target price for KINGDEE INT'L from $18.98 to $18.21 while maintaining a "Buy" rating.
HSI Rises 435 Points as JD-SW Jumps 10% and JD LOGISTICS Soars 23%
Hong Kong Stock Market Performance: Hong Kong stocks saw significant gains, with the HSI rising 1.7% to 25,757, the HSCEI up 2.1% to 8,628, and the HSTECH increasing 3.2% to 4,947, alongside a total market turnover of $292.766 billion.
JD Series Surge: JD-SW shares surged nearly 10% to $106.6 following positive results, while JD LOGISTICS experienced a remarkable 23% increase, making it the largest gainer among blue chips.
Tech Stocks Rally: Major tech companies like TENCENT, BABA-W, and MEITUAN-W saw their stock prices rise between 3.1% and 5.2%, reflecting a broader positive trend in the tech sector.
BILIBILI-W Decline: Despite reporting a 94% increase in adjusted net profit, BILIBILI-W's stock price fell by 4.5%, contrasting with other companies that experienced gains.
HSI Rises 468 Points at Midday; JD Jumps Over 8% After Earnings; Tencent, Alibaba, and Meituan Gain 4%
Market Performance: The Hong Kong bourse experienced a strong morning session, with the Hang Seng Index (HSI) rising 468 points (1.85%) to close at 25,789, driven by gains in technology stocks.
JD Companies Surge: JD's various subsidiaries saw significant stock price increases following their earnings release, with JD Logistics soaring 21.3% and JD Health rising 3.5%.
Tech Stocks Gains: Major tech companies like Tencent, Alibaba, and Meituan also posted notable gains, with increases ranging from 3.9% to 4.3%, contributing to the overall market upswing.
AI and Cloud Stocks: AI-related stocks and cloud service providers experienced growth, with companies like Kingsoft Cloud and various AI firms seeing increases of 3.7% to 5.7%, while Bilibili's stock fell despite reporting a significant profit increase.
HSBC Research Lowers KINGDEE INT'L (00268.HK) Price Target to $17.7, Maintains Buy Rating
Share Price Movement: KINGDEE INT'L's share price has decreased by 3.027% recently, despite a 24% year-to-date increase, amid concerns about AI's impact on software.
HSBC Global Research Insights: HSBC believes that while AI can enhance ERP systems, it will not replace them due to the complexity and high expectations of corporate clients.
Revenue Model Differences: Unlike the US software sector, KINGDEE INT'L charges based on the number of modules used rather than a seat-based model, reflecting the competitive landscape in China.
Profit Forecast Adjustments: HSBC has lowered its net profit forecasts for KINGDEE INT'L by 14-25% for 2025-2027, while maintaining a Buy rating and adjusting the target price from $18.2 to $17.7.
HSI Closes Down 491 Points; Tech, Pharma, and Chinese Insurers Decline, While STANCHART Surges Over 3% After Earnings Report
Market Performance: The HSI fell by 491 points (1.8%) to 26,590, with the HSCEI and HSTECH also experiencing declines of 2.1%, closing at 9,007 and 5,270 respectively, amid a total market turnover of HKD250.992 billion.
Tech Stock Declines: Major tech stocks like TENCENT, BABA-W, and MEITUAN-W saw significant drops, with short selling ratios indicating high market activity, reflecting a broader downturn in the tech sector.
Pharmaceutical Sector Struggles: Pharmaceutical stocks continued to decline, with CSPC PHARMA and SINO BIOPHARM among the biggest losers, as short selling activity remained high in this sector.
Financial Sector Highlights: STANCHART reported a 3.1% increase in stock price after announcing a significant rise in dividend distribution, contrasting with the overall negative trend seen in Chinese insurers, which experienced declines.
HSI Declines 523 Points at Midday; KNOWLEDGE ATLAS Gains 20%; Tech, Pharma, and Chinese Insurers Underperform
Market Performance: The HSI fell 523 points (1.9%) to 26,558, with the HSCEI down 190 points (2.1%) and the HSTECH dropping 127 points (2.4%), amid a total turnover of HKD138.679 billion.
Tech Stocks Decline: Major tech stocks like TENCENT, BABA-W, and MEITUAN-W experienced significant declines, with short selling ratios indicating increased bearish sentiment.
AI and Robotics Sector Struggles: Stocks in the AI sector, including SENSETIME-W and PHANCY, saw substantial losses, while robotics stocks like DOBOT plunged over 10%.
Pharmaceutical and Insurance Stocks Down: Pharma stocks such as CSPC PHARMA and Chinese insurers like CHINA LIFE faced declines of 4-6%, reflecting a broader downturn in these sectors.
G Sachs: KINGDEE INT'L (00268.HK) Anticipated to Report Over RMB60M Profit Last Year, Falling Short of Projections; Target Price Reduced to $18.21
Goldman Sachs Outlook: Goldman Sachs maintains a positive outlook on KINGDEE INT'L (00268.HK), leveraging AI and corporate data to enhance productivity, despite a recent stock decline of 5.645%.
Profit Forecast: KINGDEE INT'L is expected to turn a profit in 2025, projecting a net profit of RMB60-100 million, although this is lower than previous estimates of RMB178 million.
Revised Profit Estimates: Goldman Sachs has reduced its profit forecasts for KINGDEE INT'L for 2025-2027 by 47%, 8%, and 6% respectively, citing higher-than-expected operating expenses.
Target Price Adjustment: The broker has lowered its target price for KINGDEE INT'L from $18.98 to $18.21 while maintaining a "Buy" rating.
